Citations

Citations to this article as recorded by  

• Clinical Determinants and Prognostic Significance of Circulating Angiopoietin-Like Protein 3 Levels in Patients With Chronic Coronary Syndrome
  Hiroki Tanaka, Yunosuke Matsuura, Kinuko Yamamoto, Soichi Komaki, Masashi Yamaguchi, Kohei Moribayashi, Takeshi Ideguchi, Michikazu Nakai, Toshihiro Tsuruda, Koichi Kaikita
  Circulation Reports.2026; 8(3): 453.     CrossRef
• CURRENT ADVANCES IN LIPOPROTEIN(A) MANAGEMENT: CLINICAL SIGNIFICANCE AND EMERGING THERAPIES
  Szymon Zysiak, Rafał Bednarczyk, Natalia Bednarczyk, Agnieszka Kurek, Natalia Krajewska, Aleksandra Lejman, Aleksandra Mazurkiewicz, Hubert Sidor, Monika Wołosik, Radosław Krzysztof Binkowski
  International Journal of Innovative Technologies in Social Science.2026;[Epub]     CrossRef
• Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk in Populations With Different Low‐Density Lipoprotein Cholesterol Elevations: A Prospective Cohort Study
  Hong Zheng, Guanlin Chen, Zhenyu Huo, Yulong Lan, Yuxian Wang, Peng Fu, Weiqiang Wu, Haixiang Zheng, Kuangyi Wu, Zegui Huang, Dan Wu, Shouling Wu, Youren Chen
  Journal of the American Heart Association.2026;[Epub]     CrossRef
• The mechanism of perilla oil in regulating lipid metabolism
  Jiawei Xia, Yi Wang, Xin Li, Li Liu, Pin Zhang, Wendong Dai, Peng Luo, Guoze Wang, Yanhong Li
  Food Chemistry.2025; 476: 143318.     CrossRef
• The effect of vitamin E supplementation on serum low-density lipoprotein oxidization: A systematic review and meta-analysis of clinical trials
  Sepide Amini, Fatemeh Navab, Mohammad Hossein Rouhani, Tannaz Jamialahmadi, Mohammad Bagherniya, Prashant Kesharwani, Amirhossein Sahebkar
  European Journal of Pharmacology.2025; 997: 177491.     CrossRef
• Acromegaly and the risk of cancer: a nationwide population-based cohort study in Korea
  Yeo Song Kim, Jae-Seung Yun, Hyunho Kim, Sin Soo Jeun, Bongseong Kim, Sea-Won Lee, Jung Eun Lee, Kyuho Kim, Seung-Hyun Ko, Yu-Bae Ahn, Kyungdo Han, Seung Ho Yang
  European Journal of Endocrinology.2025; 192(3): 220.     CrossRef
• Cholesterol-modifying strategies for Alzheimer disease: promise or fallacy?
  Katia Azarfar, Boris Decourt, Brandon Sanchez Camacho, John Joshua Lawrence, Tania R. Omondi, Marwan N. Sabbagh
  Expert Review of Neurotherapeutics.2025; 25(5): 521.     CrossRef
• Recent Advances in the Management of Dyslipidemia: A Systematic Review
  Huang Jacky Xiao Feng, Yousaf Adil, Moon Julie, Ahmed Ramiz, Uppal Krishma, Sudhakar Pemminati
  Cureus.2025;[Epub]     CrossRef
• Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins
  Gala Araujo, Leidy Marian Valencia, Agata Martin-Ozimek, Yosdel Soto, Spencer D. Proctor
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Statins and adhesion molecules: a review of a novel pleiotropic property of statins
  Mahvash Sadeghi, Sajad Dehnavi, Sanaz Keshavarz Shahbaz, Khadijeh Koushki, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar
  Immunologic Research.2025;[Epub]     CrossRef
• Discordance of Small Dense LDL Cholesterol Beyond LDL Cholesterol or Non–HDL Cholesterol and Carotid Plaque
  Jinqi Wang, Xiaoyu Zhao, Yanchen Zhao, Rui Jin, Yunfei Li, Jiahe Wang, Yueruijing Liu, Zhiyuan Wu, Xiuhua Guo, Lixin Tao
  JACC: Asia.2025; 5(8): 1012.     CrossRef
• Hyperlipidemia and atherosclerosis: experimental models
  K. I. Davletova, E. L. Chernolovskaya
  Bulletin of Siberian Medicine.2025; 24(2): 141.     CrossRef
• CORRECTION OF DYSLIPIDEMIA: HISTORICAL ASPECT AND CURRENT VIEW OF THE PROBLEM (REVIEW, PART IІ)
  Dmytro D. Diachuk, Galina Z. Moroz, Oleksandr M. Tkalenko
  Clinical and Preventive Medicine.2025; (4): 134.     CrossRef
• Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial
  Daniel Gaudet, Malgorzata Gonciarz, Xi Shen, Jennifer K. Leohr, Thomas P. Beyer, Jonathan W. Day, Garrett R. Mullins, Eugene Y. Zhen, Maryalice Hartley, Miriam Larouche, Robert J. Konrad, Olivier Benichou, Giacomo Ruotolo
  Nature Medicine.2025; 31(8): 2632.     CrossRef
• Post-transcriptional targeting of PCSK9 by microRNAs: From mechanisms to therapeutic potential
  Maryam Mahjoubin-Tehran, Samaneh Rezaei, Tannaz Jamialahmadi, Prashant Kesharwani, Amirhossein Sahebkar
  Human Gene.2025; 45: 201456.     CrossRef
• Assessing Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients at a Tertiary Hospital, Addis Ababa, Ethiopia
  Edomias Adyamseged Berhe, Rediet Ambachew Sema, Yididya Mehari Tesfaye, Abel Andargie Berhane, Mikale Dawit, Ephrem Mamo Gebrehiwot, Subah Abderehim Yesuf, Balamurugan Ramatchandirin
  Journal of Diabetes Research.2025;[Epub]     CrossRef
• Dendrobium huoshanense C. Z. Tang & S. J. Cheng alleviates atherosclerosis by reducing lipid and improving vascular endothelial dysfunction
  Xiang-Cheng Fan, Wei-You Cao, Min-Yang He, Hui-Kai Wang, Qing Hao, Wen-Jing Liu, Zhao-Ying Ren, Li-Jun Wang, Jing-Yu Wang, Fei-Xue Wang, Lin Jiang, Qiu-Sheng Zheng, Jun Ma, Feng Zhang, Ji-Chun Han, Lei Zheng
  Frontiers in Nutrition.2025;[Epub]     CrossRef
• Two Sides of Triglycerides in Atherogenesis: An Essential Contributor
  Anastasia V Poznyak, Sergey Kozlov, Gulalek A Babayeva, Vasily N Sukhorukov, Alexander N Orekhov
  Clinical Medicine Insights: Cardiology.2025;[Epub]     CrossRef
• Time-Restricted Eating, ANGPTL4, and Reduction in Residual Cardiovascular Risk
  Alejandro Gugliucci
  Journal of Clinical Medicine.2025; 14(19): 7026.     CrossRef
• Genetic insights into lipid traits and atherosclerosis risk: a Mendelian randomization and polygenic risk score analysis
  Hongliang Zhang, Xiaoyu Long, Guannan Niu, Wence Shi, Zhenyan Zhao, Dejing Feng, Hui Sun, Yongjian Wu
  International Journal of Surgery.2025; 111(10): 6802.     CrossRef
• Statins as Modulators of Epithelial to Mesenchymal Transition in Cardiovascular-Kidney-Metabolic Syndrome: a Comprehensive Review of Mechanisms and Therapeutic Implications
  Fatemeh Askarizadeh, Wael Almahmeed, Kasim Sakran Abass, Salim Virani, Amirhossein Sahebkar
  Current Atherosclerosis Reports.2025;[Epub]     CrossRef
• Gut microbiota–cholesterol crosstalk in cardiovascular diseases: mechanisms, metabolites, and therapeutic modulation
  Mohammad Abavisani, Seyed Mohammad Sajjadi, Negar Ebadpour, Sercan Karav, Amirhossein Sahebkar
  Nutrition & Metabolism.2025;[Epub]     CrossRef
• Innovations in Diagnosis and Treatment of Coronary Artery Disease
  Salaheldin Agamy, Sheref Zaghloul, Zahid Khan, Ahmed Shahin, Ramy Kishk, Ahmed Smman, Luciano Candilio
  Diagnostics.2025; 16(1): 98.     CrossRef
• The role of adherence in patients with chronic diseases
  Michel Burnier
  European Journal of Internal Medicine.2024; 119: 1.     CrossRef
• Bempedoic acid: new evidence and recommendations on use
  Kristina Paponja, Ivan Pećin, Željko Reiner, Maciej Banach
  Current Opinion in Lipidology.2024; 35(1): 41.     CrossRef
• Genetic insights into repurposing statins for hyperthyroidism prevention: a drug-target Mendelian randomization study
  Anqi Huang, Xinyi Wu, Jiaqi Lin, Chiju Wei, Wencan Xu
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Targeting host-specific metabolic pathways—opportunities and challenges for anti-infective therapy
  Monika I. Konaklieva, Balbina J. Plotkin
  Frontiers in Molecular Biosciences.2024;[Epub]     CrossRef
• Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect?
  Petros Adamidis, Despoina Pantazi, Iraklis Moschonas, Evangelos Liberopoulos, Alexandros Tselepis
  Journal of Cardiovascular Development and Disease.2024; 11(3): 72.     CrossRef
• Modulating effects of crocin on lipids and lipoproteins: Mechanisms and potential benefits
  Habib Yaribeygi, Mina Maleki, Farin Rashid-Farrokhi, Payman Raise Abdullahi, Mohammad Amin Hemmati, Tannaz Jamialahmadi, Amirhossein Sahebkar
  Heliyon.2024; 10(7): e28837.     CrossRef
• Assessing the Benefits of Lifestyle Influences on Cardiovascu-lar Health After Acute Coronary Syndrome
  Marius Rus, Claudia Elena Stanis, Paula Marian, Lilliana Oana Pobirci, Loredana Ioana Banszki, Veronica Huplea, Gheorghe Adrian Osiceanu, Bianca-Maria Pop, Gabriela Dogaru, Felicia Liana Andronie-Cioara
  Balneo and PRM Research Journal.2024; 15(Vol.15, no): 660.     CrossRef
• ​Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction
  Ziyi Sun, Zhangjun Yun, Jianguo Lin, Xiaoning Sun, Qingqing Wang, Jinlong Duan, Cheng Li, Xiaoxiao Zhang, Siyu Xu, Zeqi Wang, Xingjiang Xiong, Kuiwu Yao
  Journal of Translational Medicine.2024;[Epub]     CrossRef
• Hypercholesterolemia: a literature review on management using tafolecimab: a novel member of PCSK9 monoclonal antibodies
  Zaheer Qureshi, Mikail Khanzada, Adnan Safi, Eeshal Fatima, Faryal Altaf, Timothy J. Vittorio
  Annals of Medicine & Surgery.2024; 86(5): 2818.     CrossRef
• Therapeutic approach in the treatment of dyslipidemia: Novelties and challenges
  Katarina Lalić, Nataša Rajković, Ljiljana Popović, Sandra Singh-Lukač, Iva Rasulić, Ana Petakov, Milica Krstić, Marija Mitrović
  Galenika Medical Journal.2024; 3(9): 31.     CrossRef
• Lipid Variability Induces Endothelial Dysfunction by Increasing Inflammation and Oxidative Stress
  Marie Rhee, Joonyub Lee, Eun Young Lee, Kun-Ho Yoon, Seung-Hwan Lee
  Endocrinology and Metabolism.2024; 39(3): 511.     CrossRef
• Exploring the Perceptions and Behaviours of UK Prescribers Concerning Novel Lipid-Lowering Agent Prescriptions: A Qualitative Study
  Sarah Baig, Shahrauz Mughal, Yousuf Murad, Mandeep Virdee, Zahraa Jalal
  Pharmacy.2024; 12(4): 104.     CrossRef
• Need of education and training of healthcare professionals on the PCSK9 inhibitors in cardiovascular disease
  Jan Schjøtt, Kristine Heitmann
  European Journal of Cardiovascular Nursing.2024; 23(8): e191.     CrossRef
• CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitis
  Xize Wu, Changbin Yuan, Jiaxiang Pan, Yi Zhou, Xue Pan, Jian Kang, Lihong Ren, Lihong Gong, Yue Li
  Scientific Reports.2024;[Epub]     CrossRef
• Lessons from PROMINENT and prospects for pemafibrate
  Jean-Charles Fruchart, Jamila Fruchart-Najib, Shizuya Yamashita, Peter Libby, Koutaro Yokote, Tatsuhiko Kodama, Yohei Tomita, Paul M. Ridker, Michel P. Hermans, Alberto Zambon
  Cardiovascular Diabetology.2024;[Epub]     CrossRef
• A novel lncRNA GM47544 modulates triglyceride metabolism by inducing ubiquitination-dependent protein degradation of APOC3
  Qianqian Xiao, Luyun Wang, Jing Wang, Man Wang, Dao Wen Wang, Hu Ding
  Molecular Metabolism.2024; 88: 102011.     CrossRef
• Advances in pharmacotherapy of dyslipidemia
  Harshitha Chinta
  National Journal of Pharmacology and Therapeutics.2024; 2(2): 68.     CrossRef
• ANGPTL3 as a target for treating lipid disorders in type 2 diabetes patients
  Jingfei Chen, Qin Luo, Yanfeng Yi, Jiangang Wang, Pengfei Chen, Fei Luo, Zhenfei Fang
  Lipids in Health and Disease.2024;[Epub]     CrossRef
• Assessing the effects of HMGCR, LPL, and PCSK9 inhibition on sleep apnea: Mendelian randomization analysis of drug targets
  Wei Tan, Xiujuan Deng, Xiaoning Tan, Guangbo Tan
  Medicine.2024; 103(43): e40194.     CrossRef
• Causal association between remnant cholesterol level and risk of cardiovascular diseases: a bidirectional two sample mendelian randomization study
  Lei Zhong, Bo Xie, Hai-Li Wang, Xiao-Wei Ji
  Scientific Reports.2024;[Epub]     CrossRef
• A bibliometric analysis of immunotherapy for atherosclerosis: trends and hotspots prediction
  Jing-Hui Wang, Guan-Rui Pan, Long Jiang
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Liver cancer cells as the model for developing liver-targeted RNAi therapeutics
  Beibei Hou, Linhui Qin, Linfeng Huang
  Biochemical and Biophysical Research Communications.2023; 644: 85.     CrossRef
• Insights into Causal Cardiovascular Risk Factors from Mendelian Randomization
  C. M. Schooling, J. V. Zhao
  Current Cardiology Reports.2023; 25(2): 67.     CrossRef
• Secoisolariciresinol diglucoside and anethole ameliorate lipid abnormalities, oxidative injury, hypercholesterolemia, heart, and liver conditions
  Sana Noreen, Habib‐ur Rehman, Tabussam Tufail, Huma Badar Ul Ain, Chinaza Godswill Awuchi
  Food Science & Nutrition.2023; 11(6): 2620.     CrossRef
• Colesterol remanente, riesgo vascular y prevención de la arteriosclerosis
  Xavier Pintó, Marta Fanlo, Virginia Esteve, Jesús Millán, Agustín Blanco, Mariano Blasco, José Luís Díaz Díaz, Ángel Díaz Rodríguez, Alipio Mangas, Vicente Pascual, Juan Pedro Botet, Pablo Pérez Martínez
  Clínica e Investigación en Arteriosclerosis.2023; 35(4): 206.     CrossRef
• Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
  Michael J. Wilkinson, Norman E. Lepor, Erin D. Michos
  Journal of the American Heart Association.2023;[Epub]     CrossRef
• The cell origins of foam cell and lipid metabolism regulated by mechanical stress in atherosclerosis
  Zhi Ouyang, Jian Zhong, Junyi Shen, Ye Zeng
  Frontiers in Physiology.2023;[Epub]     CrossRef
• Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
  Alejandro Gugliucci
  Journal of Clinical Medicine.2023; 12(13): 4399.     CrossRef
• Remnant cholesterol, vascular risk, and prevention of atherosclerosis
  Xavier Pintó, Marta Fanlo, Virginia Esteve, Jesús Millán
  Clínica e Investigación en Arteriosclerosis (English Edition).2023; 35(4): 206.     CrossRef
• Antibiotics and Lipid-Modifying Agents: Potential Drug–Drug Interactions and Their Clinical Implications
  Marios Spanakis, Danny Alon-Ellenbogen, Petros Ioannou, Nikolaos Spernovasilis
  Pharmacy.2023; 11(4): 130.     CrossRef
• Advances in Treatment of Dyslipidemia
  Jill Dybiec, Wiktoria Baran, Bartłomiej Dąbek, Piotr Fularski, Ewelina Młynarska, Ewa Radzioch, Jacek Rysz, Beata Franczyk
  International Journal of Molecular Sciences.2023; 24(17): 13288.     CrossRef
• Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease
  Elena Valeria Fuior, Evangelia Zvintzou, Theodosios Filippatos, Katerina Giannatou, Victoria Mparnia, Maya Simionescu, Anca Violeta Gafencu, Kyriakos E. Kypreos
  Biomedicines.2023; 11(10): 2696.     CrossRef
• Preparation, characterization and in vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles
  Lixin Du, Huiling Lu, Yifei Xiao, Zhihua Guo, Ya Li
  Scientific Reports.2023;[Epub]     CrossRef
• Dysregulation of Cholesterol Homeostasis in Ovarian Cancer
  Zahraa Qusairy, Anne Gangloff, Shuk On Annie Leung
  Current Oncology.2023; 30(9): 8386.     CrossRef
• Riesgo residual. Conclusiones
  Ángel Cequier, José Luis Zamorano
  Revista Española de Cardiología Suplementos.2023; 23: 25.     CrossRef
• Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study
  Zilong Tan, Jing Hong, Aochuan Sun, Mengdi Ding, Jianwu Shen
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Bibliometric analysis of residual cardiovascular risk: trends and frontiers
  Lin Wang, Sutong Wang, Chaoyuan Song, Yiding Yu, Yuehua Jiang, Yongcheng Wang, Xiao Li
  Journal of Health, Population and Nutrition.2023;[Epub]     CrossRef
• Current Understanding on the Genetic Basis of Key Metabolic Disorders: A Review
  Kenneth Francis Rodrigues, Wilson Thau Lym Yong, Md. Safiul Alam Bhuiyan, Shafiquzzaman Siddiquee, Muhammad Dawood Shah, Balu Alagar Venmathi Maran
  Biology.2022; 11(9): 1308.     CrossRef
• Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia
  Joon Ho Moon, Kyuho Kim, Sung Hee Choi
  Endocrinology and Metabolism.2022; 37(4): 575.     CrossRef